Azalea Vision

We are developing a Smart Contact Lens platform for patients suffering from Irregular Astigmatism, Photophobia, or Presbyopia. A dynamic light filter within the lens, adapts to brightness and modifies the artificial pupil size, compensating for refractive errors, reducing light sensitivity, and enhancing visual acuity.

Our innovative product integrates a dynamic light filter within the lens, adapting to brightness and modifying the artificial pupil size. This non-surgical approach effectively compensates for refractive errors, reduces light sensitivity, and enhances visual acuity. Our technology, based on thin liquid crystal cells and custom-made ASIC technologies, is embedded in a contact lens with an integrated micro battery and RF antenna for easy recharging and programming. This unique, patient-centric solution addresses significant gaps in current ocular treatments, offering improved quality of life and reduced healthcare costs.

**Market Opportunity:**

The specialized contact lens market is vast, with many patients dissatisfied with current solutions due to poor visual acuity. Patients, Ophthalmologists and Opticians are looking for solutions to fully address patients challenges. Our product addresses this gap, catering to over 40 million people globally suffering from eye disorders like keratoconus, presbyopia, and photophobia. The potential market size is significant, offering a substantial opportunity for growth and impact.

Specialised contact lens market already exists with several big players providing medically necessary contact lenses. Many patients not satisfied with actual solutions due to low visual acuity. Patients, Ophthalmologists and Opticians looking for solutions to fully address patients challenges.

**Competitive Advantage:**

Azalea Vision sets itself apart from top competitors with its non-surgical, comfortable treatment option. Our technology offers improved Quality of Life (QoL) for patients and a more affordable alternative in eye care, potentially reducing overall healthcare costs. With a working prototype, positive initial discussions with the FDA, and a Scientific Advisory Board in place, we are well-positioned to lead in this space.

**Business Model:**

Azalea Vision operates on a premium product model, targeting specialized centers in Europe and the USA. Our strategy is to achieve a 10% adoption rate in 150 centers within 5 years of commercialization, aiming for €130 million in revenue. We plan to offer our smart contact lenses through direct sales to specialized eye care centers, supported by robust marketing and education campaigns to ensure widespread adoption and understanding of the product's unique benefits.